TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to ...

Every major AI platform already has distribution. OpenAI has it. Anthropics has it. Google has it. So when an early-stage ...

Reconciliations and other explanations of those non-GAAP financial measures can be found in today's press release and in the earnings supplement, each of which are available on the company's IR site.

OpenAI has finalised The Deployment Company, a $10bn joint venture with TPG, Brookfield, Bain, and 16 other investors.

Declined 17%, continuing a downward trend since mid-2022, partially offset by a 4% increase in sales volumes and a 16% ...

CNW/ - Wajax Corporation ("Wajax" or the "Corporation") today announced its 2026 first quarter results. All monetary amounts ...

Management reported, "we expect the acquisitions to accelerate rate base growth to approximately 10% annually through 2029." The CFO said, "our full year 2025 results to be in line with our guidance ...

Amazon also offers distribution, fulfillment, and parcel shipping services, allowing companies to take advantage of its ...

Commercial Cell and Gene Therapy Revenue -- $9.1 million, up 26% year over year, reflecting growth in therapies supported.

Premium Weilianda theater seating delivers zero-gravity comfort, durability, smart features, boosting long-term media room value.

Aimia Inc. (JSE: AII) announced that it repurchased and settled for cancellation a total of 228,900 of its common shares in the month of April 2026 under the Company's normal course issuer bid program ...

First quarter net sales totaled $121.1 million , up 23.9% over last year; Rail segment sales growth was exceptionally strong improving 38.4% , ...